AMELIA CICCARELLI: Open Payments
NPI 1831443027 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 43 payments from 13 companies in 2025. Trend: 2023 $104 · 2024 $376 · 2025 $715
Food & beverage: $702Education: $12
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $212 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $119 |
| Lilly USA, LLC | 3 | $67 |
| Gilead Sciences, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 6 | $49 |
| PFIZER INC. | 2 | $43 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| QOL Medical, LLC | 1 | $32 |
| Ardelyx, Inc. | 1 | $32 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $23 |
Products named: TREMFYA, ENTYVIO, OMVOH, VOQUEZNA, IQIRVO, Sucraid, IBSRELA, Linzess.
Industry payments across NY — which companies pay providers there.
